A NEW APPROACH FOR EVALUATION OF THE IN-VITRO HEMOLYTIC POTENTIAL OF A SOLUTION OF A NEW MEDICINE

Citation
G. Dalnegro et P. Cristofori, A NEW APPROACH FOR EVALUATION OF THE IN-VITRO HEMOLYTIC POTENTIAL OF A SOLUTION OF A NEW MEDICINE, Comparative haematology international, 6(1), 1996, pp. 35-41
Citations number
15
Categorie Soggetti
Hematology
ISSN journal
09387714
Volume
6
Issue
1
Year of publication
1996
Pages
35 - 41
Database
ISI
SICI code
0938-7714(1996)6:1<35:ANAFEO>2.0.ZU;2-W
Abstract
In the process of developing an intravenously injectable drug, its hae molytic potential must be considered. There are no Regulatory Guidelin es for this kind of test. Many authors have set up different models, a ttempting to obtain early information about the behaviour of test comp ounds when injected into the bloodstream. In the present work, an in v itro 'static' model is presented, which takes into account the injecti on rate (R(inj.)) of the drug, and the blood flow rate (Q(v)) of the v ein in which the drug must be injected. From the relationship between these two parameters, the C-max, expressed as mg/ml, can be calculated . This latter parameter allows us to calculate the drug concentration which, at any moment during injection, comes into contact with a known aliquot of 'new' blood passing through the injection site. Furthermor e, a 'dynamic' test has been developed, which simulates an injection i nto the blood flow using a tubing system and infusion pumps set for th e same R(inj.) and Q(v) values used in 'static' test. Two injectable d rugs, Valium(R) and Lanoxin(R), and a commonly used vehicle, propylene glycol, have been tested by both the methods. These compounds have al so been tested with another in vitro method (Prieur et al. 1973), in w hich a volumetric blood-to-test solution ratio of 1:1 is adopted for e very drug tested, with neither R(inj.) nor Q(v) being taken into accou nt. Results of the haemolytic potential obtained with the three tests have been compared. A good correlation has been observed between the ' static' and the 'dynamic' tests, whereas Prieur's model, which uses a drug-to-blood ratio which is far higher than in vivo, has been shown t o give false positive results. It is concluded that a test for the eva luation of the haemolytic potential of drugs must take into account th e pharmacodynamic characteristics of the formulation intended to be in jected, and at least the blood flow rate. The proposed 'static' test h as been demonstrated to be an easy and reliable method of obtaining a true picture of the in vivo situation.